U.S. Markets open in 7 hrs 44 mins

Results hurt by patent expirations: Eli Lilly CEO

John Lechleiter, Eli Lilly CEO, breaks down the pharmaceutical giant's quarterly results. And Lechleiter weighs in on the benefits of investing in R&D.